Enhancing spinal cord stimulation-induced pain inhibition by augmenting endogenous adenosine signalling after nerve injury in rats
- 2 February 2024
- journal article
- research article
- Published by Elsevier in British Journal of Anaesthesia
- Vol. 132 (4) , 746-757
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (NS110598, NS117761)
- Medtronic
This publication has 40 references indexed in Scilit:
- A3 adenosine receptor agonist IB-MECA reverses chronic cerebral ischemia-induced inhibitory avoidance memory deficitEuropean Journal of Pharmacology, 2022
- Adenosine signaling mediate pain transmission in the central nervous systemPurinergic Signalling, 2022
- Purinergic signalling in spinal pain processingPurinergic Signalling, 2020
- Neurokinin 1 receptor activation in the rat spinal cord maintains latent sensitization, a model of inflammatory and neuropathic chronic painNeuropharmacology, 2020
- Spinal Cord Stimulation Enhances Microglial Activation in the Spinal Cord of Nerve-Injured RatsNeuroscience Bulletin, 2020
- Adenosine receptor targets for painNeuroscience, 2016
- Adenosine 2A receptor agonism: A single intrathecal administration attenuates motor paralysis in experimental autoimmune encephalopathy in ratsBrain, Behavior, and Immunity, 2015
- Spinal Cord Stimulation: Neurophysiological and Neurochemical Mechanisms of ActionCurrent Pain and Headache Reports, 2012
- Intrathecal baclofen as adjuvant therapy to enhance the effect of spinal cord stimulation in neuropathic pain: a pilot studyEuropean journal of pain, 2004
- A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesiaPain, 1988